Literature DB >> 171221

Immunisation trials with live attenuated cytomegalovirus TOWNE 125.

M Just, A Buergin-Wolff, G Emoedi, R Hernandez.   

Abstract

Trials with live cytomegalovirus (TOWNE 125 strain), which was attenuated by 125 passages exclusively on WI-38 cells, were done in adult volunteers. No virus take occured after oral/nasal application. When 10(3) TCD50 was given intramuscularly an IgG antibody response was detected at four weeks in all of ten volunteers tested by immunofluorescence; an IgM response was found in seven. Only mild local side-effects and relative lymphocytosis were observed. No virus excretion was found. Many questions remain to be answered by further trials before a cytomegalovirus vaccine can be given to adolescent girls.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171221     DOI: 10.1007/bf01641052

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  Virus studies in the treatment of congenital cytomegalovirus infections by cytosine arabinoside.

Authors:  G Emödi; J Sartorius; M Just; F Rohner; U Bühler
Journal:  Helv Paediatr Acta       Date:  1972-12

2.  [Experiences with immunofluorescence determination of antibodies to cytomegalovirus].

Authors:  H Schmitz; R Haas
Journal:  Z Med Mikrobiol Immunol       Date:  1970

3.  Cytomegalovirus infections in newborn infants.

Authors:  G Birnbaum; J I Lynch; A M Margileth; W M Lonergan; J L Sever
Journal:  J Pediatr       Date:  1969-11       Impact factor: 4.406

4.  Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

Authors:  S D Elek; H Stern
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

5.  Cytomegalovirus complement-fixing antibody in microcephaly.

Authors:  J B Hanshaw
Journal:  N Engl J Med       Date:  1966-09-01       Impact factor: 91.245

6.  Separation of rubella IgM, IgA, and IgG antibodies by gel filtration on agarose.

Authors:  A Bürgin-Wolff; R Hernandez; M Just
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

  6 in total
  13 in total

1.  [Experiments with simultaneous immunization against cytomegalovirus infection and rubella].

Authors:  M Just; A Bürgin-Wolff; R Hernandez
Journal:  Soz Praventivmed       Date:  1976 Sep-Oct

2.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

3.  Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice.

Authors:  Weijia Wang; Shannon L Taylor; Stacey A Leisenfelder; Robert Morton; Jennifer F Moffat; Sergey Smirnov; Hua Zhu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Strain variations in single amino acids of the 86-kilodalton human cytomegalovirus major immediate-early protein (IE2) affect its functional and biochemical properties: implications of dynamic protein conformation.

Authors:  M Inmaculada Barrasa; Noam Harel; Yongjun Yu; James C Alwine
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 5.  The history of vaccination against cytomegalovirus.

Authors:  Stanley Plotkin
Journal:  Med Microbiol Immunol       Date:  2015-03-20       Impact factor: 3.402

6.  A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men.

Authors:  Stuart P Adler; Anne-Marie Manganello; Ronzo Lee; Michael A McVoy; Daniel E Nixon; Stanley Plotkin; Edward Mocarski; Josephine H Cox; Patricia E Fast; Pavlo A Nesterenko; Susan E Murray; Ann B Hill; George Kemble
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

7.  A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.

Authors:  Christina Jenkins; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Adverse effects of cytomegalovirus vaccination in mice.

Authors:  M C Jordan
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

Review 9.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92.

Authors:  Basel T Assaf; Keith G Mansfield; Lisa Strelow; Susan V Westmoreland; Peter A Barry; Amitinder Kaur
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.